revention
and treatment of chemical dependence among anesthesiologists
continues to be a focus of concern and activity
for ASA. For more than 40 years, ASA has been aggressively
attacking this problem through research efforts,
educational programs and political advocacy. ASA
was instrumental in the development and implementation
of the efficient gas scavenging and air recirculation
systems that are now required at all anesthetizing
locations. ASA advocated for educational reform
that resulted in the current Accreditation Council
for Graduate Medical Education requirement for annual
education of residents in matters related to chemical
dependency. Our Task Force on Chemical Dependence,
composed of practicing anesthesiologists who also
are experts in addiction medicine, is arguably the
most visible and active such group among its peers
from other specialty societies.
In spite of these and many other efforts by ASA
as well as work by others in the field, chemical
addiction remains a concern for members of our specialty.
This concern was highlighted by a recent article
in a popular magazine.1
The article cited preliminary work that has appeared
in a number of venues and has been used to make
unsupported generalizations about the prevalence
and etiology of addiction among anesthesiologists.
The work that was featured in the Men’s
Health article was published in a series of
abstracts2,3
and journal articles.4-6
Each of these publications contains the same two
independent observations: 1) anesthesiologists are
over-represented in the Florida Recovery Program
(anesthesiologists are 25 percent of patients in
the treatment program despite comprising only 5.6
percent of Florida physicians) and are frequently
unable to return to clinical anesthesiology, and
2) very low concentrations of fentanyl are measurable
in samples of patients’ exhaled breath, in
the air around anesthesiologists’ work stations
(specifically cardiac surgery rooms) and in the
“effluvia” (sic) from the cardiopulmonary
bypass machine.
Neither of these two findings is unique or surprising.
Using data collected from treatment programs, many
authors have reported an excess of chemical dependence
in certain medical specialties, including anesthesiology.
Whether this truly represents an increased incidence
of the disease or simply an increase in reporting
of the disease among anesthesiologists remains in
question. Similarly there is extensive literature
on the exposure of health care personnel to trace
anesthetic gases. To date, there is no evidence
of adverse health effects resulting from the low
levels of exposure found in a modern adequately
scavenged and ventilated operating room.
What is surprising is the attempt to link these
two independent observations with the claim that
exposure to the trace amount of ambient fentanyl
in the workplace environment is the source of the
excess prevalence of addiction among anesthesiologists.
The authors’ hypothesis states that fentanyl
given for surgical anesthesia enters the atmosphere
as a result of leakage from intravenous injection
sites, open ampules and from the patient’s
exhaled breath. They then posit that anesthesiologists
are more susceptible to opiate addiction because
they become sensitized from chronic exposure to
this ambient fentanyl in the operating room air.
They conclude that fentanyl in the operating room
air “can be expected… to change the
brain, motivation and behavior” of an anesthesiologist5
and could result in “place preference, abstinence-like
withdrawal dysphoria, and even an acquired drive
for the drug.”3
In our opinion, there are several problems with
the data used to draw these conclusions:
1. There is an incomplete description of the
methodology by which air samples are collected
in the operating room as well as the assay techniques
used to detect the ambient fentanyl.
2. The concentration of ambient fentanyl is poorly
quantitated. The only quantitative information
is the comment in one article that fentanyl was
found “in excess of 1 nanomole per liter.”4
3. There is no accounting for waste gas scavenging
and air recirculation in the operating rooms,
which would be expected to remove any trace narcotic
vapors from the air.
4. The authors have not demonstrated that fentanyl
in the air actually enters the bloodstream or
brain of anesthesiologists.
5. There is no evidence presented that the exposure
suggested by these studies changes the brain or
learned behavior of anesthesiologists.
6. The data presented in the publications do not
prove causality or even an association between
this possible source of exposure to fentanyl and
the disease of chemical dependence in anesthesiologists.
The hypothesis presented in the referenced articles
is intriguing, but the conclusions are premature
and not supported by data. Much more work remains
to be done, and independent confirmation of the
data is necessary to confirm or reject the hypothesis.
We look forward to peer-reviewed publication of
results to answer questions such as ours and those
posted by other experts in the field.7-9
Until more is known, the theory must be viewed with
caution.
References:
1. McDougall CM. The junkie in the O.R. Men’s
Health. 2006; 11:186-193.
2. Gold MS, Melker RJ, Pomm R, et al. Anesthesiologists
are exposed to fentanyl in the operating room: Addiction
may be due to sensitization. XXIVth CINP Congress.
Paris, France, 2004.
3. Gold MS, Dennis DM, Morey TE, et al. Addiction:
An occupational hazard for anesthesiologists. Anesthesiology.
2004; 101:A1323.
4. Gold MS, Dennis DM, Morey TE, Melker RJ. Exposure
to narcotics in the operating room poses occupational
hazard for anesthesiologists. Psychiatric Annals.
2004; 34:794-797.
5. Gold MS, Melker RJ, Dennis DM, et al. Fentanyl
abuse and dependence: Further evidence for second-hand
exposure hypothesis. J Addict Dis. 2006;
25:15-21.
6. McAuliffe PF, Gold MS, Bajpai L, et al. Second-hand
exposure to aerosolized intravenous anesthetics
propofol and fentanyl may cause sensitization and
subsequent opiate addiction among anesthesiologists
and surgeons. Med Hypotheses. 2006; 66:874-882.
7. Cohen PJ. Fentanyl abuse and dependence: Further
evidence for second-hand exposure hypothesis. Comments
by Peter J. Cohen. J Addict Dis. 2006;
25:135-136: discussion 41-44.
8. Denisco RA. Fentanyl abuse and dependence: Further
evidence for second-hand exposure hypothesis. Comments
by Richard A. Denisco. J Addict Dis. 2006;
25:137; discussion 41-44.
9. Gorman E. Fentanyl abuse and dependence: Further
evidence for second-hand exposure hypothesis. Comments
by Eugene Gorman. J Addict Dis. 2006; 25:139-140;
discussion 41-44.
| |
|
Susan L. Polk, M.D., M.S.Ed., is former Professor
of Anesthesia and Critical Care, University
of Chicago, Chicago, Illinois. She is now retired. |
|
| |
|
Jonathan D. Katz, M.D., is Clinical Professor
of Anesthesiology, Yale University School of
Medicine and Attending Anesthesiologist, St.
Vincent Medical Center, Bridgeport, Connecticut. |
|
| |
|
Arnold J. Berry, M.D., M.P.H., is Professor
of Anesthesiology, Emory University School of
Medicine, Atlanta, Georgia. |
|
| |
|
Diana G. McGregor, M.B.B.S., F.R.C.A. is Clinical
Associate Professor of Anesthesia, Stanford
University, Stanford, California. |
|
| |
|
William P. Arnold III, M.D., is Associate Professor
of Anesthesiology, University of Virginia Health
System, Charlottesville, Virginia. |
|
|